We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Software Platform Integrates Interventional Image-Guided Procedures

By MedImaging International staff writers
Posted on 06 Jun 2019
Print article
Image: The IntraSight platform combines iFR, FFR, IVUS and co-registration modalities to simplify complex interventions (Photo courtesy of Philips Healthcare).
Image: The IntraSight platform combines iFR, FFR, IVUS and co-registration modalities to simplify complex interventions (Photo courtesy of Philips Healthcare).
A new interventional applications platform combines physiology, imaging, and co-registration tools to provide cardiac and peripheral vascular patients with superior care.

The Royal Philips (Amsterdam, The Netherlands) IntraSight interventional applications platform is a scalable system based on Philips’ common software and hardware architecture. IntraSight provides seamless integration with the Allura and Azurion iXR image-guided therapy (IGT) systems, optimizing interventional lab performance with new tableside touch screen control, data management, and Philips remote services (PRS) diagnostics that provide corrective action planning, improved uptime, increased case efficiency, and reduced errors.

The comprehensive applications suite includes instant wave free ratio (iFR), fractional flow reserve (FFR), intravascular ultrasound (IVUS), and co-registration modalities to simplify complex interventions and speed routine procedures. Patient information is thus entered only once, generating a single case menu that is shared between iFR/FFR and IVUS modalities, which can also be imported from Azurion or Allura coronary suites with a touch of a button. For non-Philips catheterization labs, the data can be imported using digital imaging and communications in medicine (DICOM) worklists.

iFR is an innovative pressure-derived index proprietary to Philips, allowing a simplified hyperemia-free physiological assessment of coronary blockages. Using iFR pullback and co-registration and IVUS co-registration with the angiogram, interventional physicians can identify the precise locations that are causing ischemia, map both the pressure profile and IVUS measurements of the whole vessel onto the angiogram, plan stent length and placement with the aid of a virtual stent, and predict potential physiologic improvement.

“The range and complexity of cardiovascular diseases that can be treated with minimally invasive procedures continues to expand. The procedures themselves are also becoming more complex, increasing the demands on physicians to integrate different sources of information, decide on the best course of treatment for each patient, act on that decision and confirm the treatment’s effectiveness,” said Bert van Meurs, chief business leader of IGT at Royal Philips. “IntraSight is an important step forward in integrating intravascular diagnostic applications into a smart, simple and seamless workflow in the interventional lab.”

“IntraSight has made an immediate impact in our lab,” said Rasha Al-Lamee, MD, clinical academic interventional cardiology consultant at Imperial College Healthcare NHS Trust (London, United Kingdom). “It is so simple and intuitive to use that it took us no time at all to get used to it. It has made using physiology and imaging even quicker and easier, which is a great advance for us and for our patients.”


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Compact C-Arm with FPD
Arcovis DRF-C R21
MRI System
uMR 588
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.